I mean what are people else going to do, die? Oh wait.
I don't understand commenters in this thread coming out in defense of pharmacy companies using their monopoly or influence to deny health care to people that need it. It should be considered a criminal offense. It's anti-competitive. I mean with insulin it's a massive hole in the market - why hasn't anyone else been able to jump into that gap and make a killing?
That's 6% not 1% of the cost of new ones, though.
>McInnis explained since 2000, Walmart has sold ReliOn insulin, the only private insulin brand on the market retailing at $24.88 per vial.
https://www.wfmynews2.com/article/news/verify-yes-walmart-do...
Walmart just started selling analog insulin(the newer formulation) just recently. https://nypost.com/2021/06/29/walmart-to-launch-its-own-low-...
Medicine isn't like a supermarket, people usually just take what their doctor/hospital prescribes. In addition, I think it's likely that those with no/worse health insurance are on average less informed.
I would think it's weird if my doc assumes I just want the cheapest available option.
We saw something similar happen during the pandemic. There has to be infrastructure and people with the skill and knowledge to support an industry available, and even if you had those people available you can't just ramp up production in any old place. That's why there were supply chain problems and will continue to be, the UK won't be making its own drugs (designing, yes, making, no) just because it did in the past, the US won't be making computer chips just because it did in the past. There being a profit to be made isn't enough.
> You are giving far too much credit to what is on the face of it a broken system.
The system may be broken but fixing it takes more than a wave of the hand.
Anyone making the decade-old version of insulin and selling it for 1% of the price would corner a large portion of the market immediately. Anyone without good health insurance, which is a large and increasing part of the population, would immediately jump on the lower priced version.
And since when are insurance companies excited to pay for the more expensive drug with limited extra utility anyway?
You are giving far too much credit to what is on the face of it a broken system.